Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Cornerstone Eye Care
mi
from
High Point, NC
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Cornerstone Eye Care
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
James D. Branch, MD
mi
from
Winston-Salem, NC
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
James D. Branch, MD
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Legacy Good Samaritan - Devers Eye Institute
mi
from
Portland, OR
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Legacy Good Samaritan - Devers Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Scott & Christie and Associates, PC
mi
from
Cranberry Township, PA
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Scott & Christie and Associates, PC
mi
from
Cranberry Township, PA
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Philadelphia Eye Associates
mi
from
Philadelphia, PA
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Philadelphia Eye Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Keystone Research Ltd.
mi
from
Austin, TX
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Keystone Research Ltd.
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Glaucoma Associates of TX
mi
from
Dallas, TX
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Glaucoma Associates of TX
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
R and R Eye Research, LLC
mi
from
San Antonio, TX
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
R and R Eye Research, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Focus Clinical Research
mi
from
Salt Lake City, UT
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Focus Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Spokane Eye Clinical Research
mi
from
Spokane, WA
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Spokane Eye Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/11/2018
Melbourne Eye Specialists
mi
from
Fitzroy,
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/11/2018
Melbourne Eye Specialists
mi
from
Fitzroy,
Click here to add this to my saved trials
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
Status: Enrolling
Updated:  1/11/2018
Duke Univ Med Ctr
mi
from
Durham, NC
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
Status: Enrolling
Updated: 1/11/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Stanford University
mi
from
Stanford, CA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Ohio State University
mi
from
Columbus, OH
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
Status: Enrolling
Updated:  1/16/2018
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
Status: Enrolling
Updated: 1/16/2018
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 01
mi
from
Orlando, FL
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 01
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 11
mi
from
San Diego, CA
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 11
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 03
mi
from
San Francisco, CA
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 03
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 16
mi
from
Denver, CO
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 16
mi
from
Denver, CO
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 05
mi
from
Sarasota, FL
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 05
mi
from
Sarasota, FL
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 07
mi
from
Pittsburg, KA
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 07
mi
from
Pittsburg, KA
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 08
mi
from
Warrensburg, MO
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 08
mi
from
Warrensburg, MO
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 09
mi
from
Vestal, NY
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 09
mi
from
Vestal, NY
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 10
mi
from
Powell, OH
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 10
mi
from
Powell, OH
Click here to add this to my saved trials
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated:  1/17/2018
Valeant Site 11
mi
from
New Berlin, WI
Clinical Study of Approved Contact Lenses
Clinical Study of Approved Contact Lenses
Status: Enrolling
Updated: 1/17/2018
Valeant Site 11
mi
from
New Berlin, WI
Click here to add this to my saved trials
Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
Sirolimus in Conjunction With EYLEA® (Aflibercept) Versus EYLEA® Alone for Exudative AMD
Status: Enrolling
Updated:  1/18/2018
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
Sirolimus in Conjunction With EYLEA® (Aflibercept) Versus EYLEA® Alone for Exudative AMD
Status: Enrolling
Updated: 1/18/2018
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
Phase II, Randomized, Double-masked, Active-controlled Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  1/19/2018
Inotek Pharmaceuticals Corporation
mi
from
Lexington, MA
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
Phase II, Randomized, Double-masked, Active-controlled Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 1/19/2018
Inotek Pharmaceuticals Corporation
mi
from
Lexington, MA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Robert Noecker, M.D., M.B.A.
mi
from
Fairfield, CT
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Robert Noecker, M.D., M.B.A.
mi
from
Fairfield, CT
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Coastal Research Associates, LLC
mi
from
Roswell, GA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Coastal Research Associates, LLC
mi
from
Roswell, GA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Heart of America Eye Care, P.A.
mi
from
Shawnee Mission, KA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Heart of America Eye Care, P.A.
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Rochester Ophthalmology Group
mi
from
Rochester, NY
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Rochester Ophthalmology Group
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
The Eye Institute
mi
from
Tulsa, OK
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
The Eye Institute
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Wills Eye Hospital
mi
from
Philadelphia, PA
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Univ Eye Surgeons, Maryville Ctr.
mi
from
Maryville, TN
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Univ Eye Surgeons, Maryville Ctr.
mi
from
Maryville, TN
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Texan Eye
mi
from
Austin, TX
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Texan Eye
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated:  1/22/2018
Comprehensive Eye Care
mi
from
Saint Louis, MO
Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure
A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure
Status: Enrolling
Updated: 1/22/2018
Comprehensive Eye Care
mi
from
Saint Louis, MO
Click here to add this to my saved trials
PIONEER: Intraoperative and Perioperative OCT Study
Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical Coherence Tomography: PIONEER Study
Status: Enrolling
Updated:  1/23/2018
Cole Eye Institute, Cleveland Clinic
mi
from
Cleveland, OH
PIONEER: Intraoperative and Perioperative OCT Study
Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical Coherence Tomography: PIONEER Study
Status: Enrolling
Updated: 1/23/2018
Cole Eye Institute, Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials